2023 Study: Cannabinoids for Brain Tumors
Welcome to Cannabis Conclusions, a unique educational series from Higher Learning LV that is targeted at hemp and cannabis industry professionals. This series provides readers with the conclusion section from important modern peer-reviewed research studies.
A 2023 study entitled "Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)" that was published in the journal Current Treatment Options in Oncology explored the ways in which the constituent chemicals offers by cannabis and hemp—including the major cannabinoids CBD and THC—may help those suffering cancerous brain tumors.
The study provided a broad overview of the current landscape for ways in which cannabis and hemp can be used to treat brain tumors, with a focus on how the quality of life of patients and the therapeutic efficacy "may be improved by the use of cannabis."
Study Conclusions
"In recent years, the medicinal properties of the Cannabis genus have received increased attention around the world. This attention combined with the lack of therapeutic choices and side effect management from such therapies has greatly increased the interest of cannabis in brain tumor patients due to its safety profile.
"Medicinal cannabis may inhibit chemotherapy-induced nausea and vomiting, stimulate appetite, reduce pain, and decrease inflammation and cancer cell proliferation and survival."
"Current evidence suggests medicinal cannabis may inhibit chemotherapy-induced nausea and vomiting, stimulate appetite, reduce pain, and decrease inflammation and cancer cell proliferation and survival. In this context, cannabinoids have not only shown to possess properties that may help minimize the polypharmacy effect that chemotherapeutic agents entail, but to be a potential co-adjuvant to these therapies.
"Cannabinoid therapies including marijuana and CBD products may be a useful adjunct to steroids and palliative therapies to improve symptom management.
"The increasing need for evidence-based arguments about potential harms and benefits of cannabis use paralleled a surge in empirical studies investigating the health impact of cannabis use, the majority of which are observational and focused upon negative health effects and addiction.
"Cannabinoid therapies including marijuana and CBD products may be a useful adjunct to steroids and palliative therapies to improve symptom management."
"Although there have been some interventional studies to try to understand the impact of cannabinoids in gliomas the use by the public in general has greatly surpassed the scientific knowledge derived from clinical trials. As such, more rigorous studies aimed to understand the overall clinical impact of cannabis and cannabinoids in patients with brain tumors and the interactions of these compounds with standard of care treatments are urgently needed."
Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.